This can happen if the medicine is exposed to light, stored at the wrong temperature, or has passed its expiry date
Published Phase 2 trial data (for example, Jastreboff et al., NEJM 2023) have explored doses ranging from approximately 1 mg up to 12 mg administered once weekly
Importantly, experiencing headaches during tirzepatide treatment does not mean the medication is wrong for youmost patients tolerate it well once the initial phase passes, and the weight loss and metabolic benefits often outweigh temporary discomfort
Standard oral supplements often break down before they get there
Semaglutide 2.4 mg once weekly is the latest approved GLP-1 RA for obesity management (2021) and results in 1517% mean WL through appetite reduction [11, 12]
With so many treatments available, many people feel confused about what actually works